Search academic texts

Information × Registration Number 0304U001009, 0102U003049 , R & D reports Title To study antituberculous activity of rifabutin and flurenizid and to work out the effective regimens of chemotherapy with using these drugs in patients with destructive pulmonary tuberculosis popup.stage_title Вивчити попередні результати лікування і бактеріостатичну активність крові при застосуванні рифабутіну і флуренізиду в комплексній хіміотерапії хворих деструктивним туберкульозом легень Head Byalik Yosyp, Registration Date 12-01-2004 Organization Institute of tuberculosis and pulmonology named by F. G. Yanovsky popup.description2 Action of rifabutin (Rb) and flurenizide (Fl) were studied on 200 patients with pulmonary destructive tuberculosis. High blood concentration and high efficacy and well tolerance were determined at using Rb in doses 0,3-0,45 g at using every next day. Fl in doses 0,6-0,9 g makes high concentration in blood during 6 hours. It is effective and well enduranced. Application sphere - phthisiology Product Description popup.authors popup.nrat_date 2020-04-02 Close